Kalaris Therapeutics, Inc. (KLRS)
NASDAQ: KLRS · Real-Time Price · USD
3.480
-0.370 (-9.61%)
At close: May 9, 2025, 4:00 PM
3.480
0.00 (0.00%)
After-hours: May 9, 2025, 4:05 PM EDT
Kalaris Therapeutics Market Cap
Kalaris Therapeutics has a market cap or net worth of $65.08 million as of May 9, 2025.
Market Cap
65.08M
Enterprise Value
83.35M
1-Year Change
n/a
Ranking
Category
Stock Price
$3.48
Market Cap Chart
Since March 19, 2025, Kalaris Therapeutics's market cap has decreased from $214.52M to $65.08M, a decrease of -69.66%. That is a compound annual growth rate of -99.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2025 | 72.00M | -66.43% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 674.60B |
| Johnson & Johnson | 374.53B |
| UnitedHealth Group | 349.75B |
| AbbVie | 328.29B |
| Novo Nordisk | 287.72B |
| Abbott Laboratories | 233.14B |
| Novartis AG | 215.89B |
| AstraZeneca | 208.98B |